⚡ Quick answer: Dog kidney disease (CKD) IRIS staging calculator. Stages chronic kidney disease 1-4 from creatinine, substages by proteinuria and blood pressure, with treatment guidance and median survival per the 2023 International Renal Interest Society guidelines.
Why IRIS Staging Matters
Chronic kidney disease (CKD) affects approximately 1 in 10 dogs over 7 years of age (O’Neill 2013 VetCompass), rising sharply with age. Without staging, CKD management is one-size-fits-all and misses the substantial differences in prognosis and treatment intensity between early disease (Stage 1) and end-stage disease (Stage 4).
The International Renal Interest Society (IRIS) publishes the global staging system for canine CKD. The 2023 IRIS guidelines use:
- Stable creatinine to assign Stage 1-4
- SDMA (symmetric dimethylarginine) as a more sensitive early marker
- Urine protein:creatinine ratio (UPC) for proteinuria substaging
- Systolic blood pressure for hypertension substaging
This calculator applies the IRIS 2023 thresholds and translates them into stage-specific treatment guidance.
The IRIS Stages
| Stage | Creatinine (mg/dL) | Creatinine (μmol/L) | Description |
|---|---|---|---|
| 1 | <1.4 | <125 | Non-azotaemic; usually identified by SDMA or imaging |
| 2 | 1.4-2.8 | 125-249 | Mild renal azotaemia; many dogs asymptomatic |
| 3 | 2.9-5.0 | 250-439 | Moderate; clinical signs usually present |
| 4 | >5.0 | >440 | Severe / end-stage; intensive support needed |
Unit conversion: mg/dL × 88.4 = μmol/L. UK and SI laboratories typically report μmol/L; US laboratories typically report mg/dL.
Why The Stage Must Be Stable
A single elevated creatinine is not a CKD diagnosis. The differentials:
Pre-Renal (most common false-positive)
- Dehydration — gastroenteritis, heatstroke, inadequate water access
- Decreased renal perfusion — heart failure, severe haemorrhage
Treatment: rehydrate, recheck — often resolves.
Post-Renal
- Urinary obstruction — bladder stones, urethral plug, prostatic disease
- Urinary rupture — trauma, severe obstruction
Treatment: relieve obstruction, recheck.
Acute Kidney Injury (AKI)
- Toxins — antifreeze, grapes/raisins, NSAIDs at toxic dose, lilies (cats more often), aminoglycoside antibiotics
- Infection — leptospirosis, pyelonephritis
- Sepsis — any severe systemic infection
- Ischaemic injury — anaesthetic hypotension, severe shock
AKI is treated differently — IV fluid diuresis, aggressive supportive care, sometimes haemodialysis. Recovery is possible.
Confirm CHRONIC by repeat creatinine 2-3 weeks apart in a stable, hydrated dog. Stage by the later, more stable reading. The same numerical creatinine has very different implications if it’s chronic vs acute.
SDMA – The Earlier Marker
Symmetric dimethylarginine (SDMA) elevates earlier than creatinine in declining renal function. Useful especially in:
- Toy and small breeds — small muscle mass keeps creatinine artificially low; SDMA catches early CKD that creatinine misses
- Older dogs with subtle PU/PD — flag early disease before azotaemia develops
- Annual senior screens — SDMA above 14 μg/dL with normal creatinine suggests Stage 1 CKD
Substage interpretation:
| SDMA (μg/dL) | Interpretation |
|---|---|
| <14 | Normal |
| 14-17 | Borderline elevated |
| ≥18 with normal creatinine | Suggestive of Stage 1 CKD |
| ≥25 in Stage 2 patient | Consider Stage 3 management |
| ≥45 in Stage 3+ patient | Consistent with Stage 4 |
Proteinuria Substaging
The IRIS proteinuria substages:
| UPC ratio | Substage |
|---|---|
| <0.2 | Non-proteinuric |
| 0.2-0.5 | Borderline proteinuric |
| >0.5 | Proteinuric |
Significance: proteinuria approximately doubles the rate of CKD progression. Treatment is one of the most evidence-based interventions:
- Telmisartan 1 mg/kg/day — angiotensin II receptor blocker; current first-line
- Benazepril 0.5 mg/kg/day — ACE inhibitor; long-established alternative
- Goal: reduce UPC by ≥50% to under 0.5; monitor every 1-2 months
Blood Pressure Substaging
The IRIS blood pressure substages:
| Systolic BP (mmHg) | Substage | Risk |
|---|---|---|
| <140 | Normotensive | Minimal |
| 140-159 | Prehypertensive | Mild |
| 160-179 | Hypertensive | Moderate — treatment indicated |
| ≥180 | Severely hypertensive | High — target-organ damage risk |
Target-organ damage from sustained hypertension:
- Retinopathy — retinal detachment, sudden blindness
- Encephalopathy — neurological signs, seizures
- Kidney damage — accelerated CKD progression
- Cardiac — left ventricular hypertrophy
First-line treatment: amlodipine 0.1-0.5 mg/kg/day; telmisartan if also proteinuric. Recheck BP in 1-2 weeks; target SBP 130-150 mmHg.
The Four Pillars of CKD Management
Regardless of stage, the four evidence-based interventions:
1. Renal Diet (Phosphorus Restriction)
The most evidence-based survival-extending intervention in canine CKD:
- Jacob 2002 JAVMA: renal-diet-fed dogs had fewer uraemic episodes and longer survival
- Plantinga 2005: median survival doubled on renal diet
Commercial veterinary renal diets:
- Hill’s k/d
- Royal Canin Renal
- Purina NF (Kidney Function)
- Specific Kidney Support
Phosphorus restriction is the active component. Add phosphate binders (aluminium hydroxide, calcium-based, lanthanum) if serum phosphorus stays elevated despite diet.
2. Hydration
- Free water access continuously
- Wet food preferred (or add water to dry)
- Sub-cutaneous fluid therapy at home for Stage 3-4 — typically 10-20 mL/kg lactated Ringer’s once daily; vets train owners
3. Proteinuria Control
- Telmisartan or benazepril if UPC >0.5
- Monitor every 1-2 months
- Goal: UPC <0.5 or 50% reduction
4. Blood Pressure Control
- Amlodipine first-line if SBP ≥160 mmHg
- Telmisartan if also proteinuric
- Target SBP 130-150 mmHg
Median Survival By Stage
Reported median survival from CKD diagnosis (varies widely by individual):
| Stage | Median survival |
|---|---|
| 1 | Years (often 2-3+); excellent if no proteinuria or hypertension |
| 2 | ~1,100 days (~3 years) in many studies |
| 3 | 100-700 days; wide variation |
| 4 | 14-80 days; hospice planning appropriate |
Caveats: these are medians, not predictions for individual dogs. Aggressive evidence-based management can substantially extend survival, especially when CKD is caught early.
What Worsens CKD
Identifiable and modifiable factors that accelerate decline:
- Dehydration — gastroenteritis, heatstroke, water access loss
- Urinary tract infection — very common in CKD dogs (urine culture every 3-6 months)
- Nephrotoxic drugs — NSAIDs, aminoglycoside antibiotics, certain chemotherapy
- Untreated hypertension
- Dietary protein excess above renal-diet level
- Hyperphosphataemia despite diet — add phosphate binders
Hospice-Friendly Interventions (Stage 4)
- Home sub-cutaneous fluid therapy — transforms quality of life in many Stage 4 dogs
- Maropitant (Cerenia) — anti-emetic for uraemic nausea
- Capromorelin (Entyce) or mirtazapine — appetite stimulants
- Gastric protectants — omeprazole for uraemic gastropathy
- Gabapentin — for any pain or anxiety component
- Pre-emptive end-of-life planning — when interventions stop working, hospice and humane euthanasia are the kind choices
The PuppaDogs Quality of Life Calculator gives a structured framework for the end-of-life decision-making process.
Breed-Predisposed Renal Disease
Some breeds carry documented elevated risk:
- Familial nephropathy in young dogs: Cocker Spaniel, Bull Terrier, Standard Poodle, Shih Tzu, Lhasa Apso, Doberman
- Renal dysplasia: Soft-Coated Wheaten Terrier, Lhasa Apso, Shih Tzu
- Hereditary nephritis: Bull Terrier, Dalmatian, English Cocker, Samoyed
- Amyloidosis: Shar Pei, Beagle, English Foxhound
For young dogs of these breeds with unexplained PU/PD, weight loss or elevated creatinine, renal-disease workup is appropriate including SDMA, UPC, and possibly renal biopsy.
Honest Caveats
- Single creatinine is not diagnostic — always confirm chronic on repeat testing.
- Owner-rated assessment of CKD severity is approximate — the lab numbers are the staging foundation.
- Treatment varies by individual — the principles are evidence-based, but specific drug choices depend on the whole clinical picture.
- Median survival is a population statistic — many dogs do far better, some do worse. The number is a planning tool, not a prediction.
- This calculator helps you understand the staging and discuss management with your vet; it does not replace the vet’s hands-on assessment, blood work interpretation, or individualised treatment plan.
Conclusion
The IRIS 2023 staging system is the international standard for canine CKD management. Stage by stable creatinine (with SDMA refining early disease); substage by proteinuria (UPC) and blood pressure; treat by the four pillars (renal diet, hydration, proteinuria control, BP control); plan for quality of life and hospice as Stage 4 approaches. With evidence-based management, many CKD dogs live years of high-quality life — and even Stage 4 can be supported humanely for weeks to months with attentive care.
Frequently Asked Questions
What are the stages of kidney disease in dogs?
The International Renal Interest Society (IRIS) 2023 staging uses stable blood creatinine: Stage 1 <1.4 mg/dL (<125 umol/L), non-azotaemic; Stage 2 1.4-2.8 mg/dL (125-249 umol/L), mild azotaemia; Stage 3 2.9-5.0 mg/dL (250-439 umol/L), moderate with clinical signs; Stage 4 >5.0 mg/dL (>440 umol/L), severe / end-stage. Substaging by proteinuria (UPC ratio) and systolic blood pressure refines management.
What is SDMA in dogs?
SDMA (symmetric dimethylarginine) is a renal biomarker that elevates EARLIER than creatinine in declining kidney function. Particularly useful in toy and small breeds where small muscle mass keeps creatinine artificially low. Reference: <14 ug/dL normal, 14-17 borderline, 18+ with normal creatinine suggests IRIS Stage 1 CKD. SDMA above 25 in a Stage 2 dog suggests Stage 3 management. Standard component of senior wellness screens.
What is the best diet for a dog with kidney disease?
A veterinary renal diet (Hill’s k/d, Royal Canin Renal, Purina NF Kidney Function, Specific Kidney Support) is the most evidence-based survival-extending intervention in canine CKD. The active ingredient is PHOSPHORUS RESTRICTION – Jacob 2002 and Plantinga 2005 RCTs showed renal diets approximately doubled median survival. Other features: moderate high-quality protein, omega-3 supplementation, low sodium, B vitamins. Transition gradually over 1-2 weeks.
How long do dogs live with kidney disease?
Depends entirely on stage and management. IRIS Stage 1: years, often 2-3+ if no proteinuria or hypertension. Stage 2: median ~1100 days (about 3 years) in many studies. Stage 3: 100-700 days, wide individual variation. Stage 4: 14-80 days, hospice planning appropriate. These are medians, not predictions – aggressive evidence-based management (renal diet, hydration support, proteinuria control, BP control) can substantially extend survival.
What is proteinuria in dogs with kidney disease?
Proteinuria means protein leaking into the urine, measured by the urine protein:creatinine ratio (UPC). Non-proteinuric <0.2, borderline 0.2-0.5, proteinuric >0.5. Proteinuria DOUBLES the rate of CKD progression and is one of the most modifiable predictors of survival. Treatment: telmisartan 1 mg/kg/day (first-line) or benazepril 0.5 mg/kg/day; goal is 50% reduction or UPC <0.5; monitor every 1-2 months.
Can dogs with kidney disease have subcutaneous fluids at home?
Yes – home sub-cutaneous fluid therapy is one of the most quality-of-life-improving interventions in canine CKD. Vets train owners to give it. Typical: lactated Ringer’s solution, 10-20 mL/kg per session, once daily for Stage 3-4 dogs (less often for Stage 2). Equipment: fluid bag, drip set, 18-20 gauge needles. Improves hydration, energy, appetite and slows CKD progression. Discuss with your vet.
Related PuppaDogs Calculators
Continue building your dog’s personalised care plan with these related PuppaDogs calculators:
- Dog Pregnancy / Whelping Due-Date Calculator
- Puppy Weight Predictor (Adult Weight Calculator)
- Heatstroke Risk Calculator for Dogs
- Bloat (GDV) Risk Calculator for Dogs
- Dog Life Expectancy Calculator (Breed, Body Condition, Lifestyle)
- Spay/Neuter Timing Calculator for Dogs (Breed-Specific)
References & Further Reading
The dosing ranges and safety information on this page are drawn from the following veterinary references. Always defer to your own veterinarian and the manufacturer’s label for your specific product.
- International Renal Interest Society (IRIS). 2023 Staging Guidelines for Canine and Feline Chronic Kidney Disease. iris-kidney.com.
- Jacob F, Polzin DJ, Osborne CA, et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic renal failure in dogs. JAVMA, 2002.
- Plantinga EA, Everts H, Kastelein AMC, Beynen AC. Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. Veterinary Record, 2005.
- Polzin DJ. Chronic Kidney Disease in Small Animal Practice. Saunders, 2017 – the standard CKD reference.
- ACVIM consensus statement on hypertension in dogs and cats (Acierno et al. JVIM 2018).
- Brown S, Atkins C, Bagley R, et al. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. JVIM, 2007.
- PuppaDogs. Water Intake & Polydipsia Calculator and Quality of Life Calculator. puppadogs.com.
⚕️ Medical disclaimer
The information on this page is intended for educational purposes only and does not replace a hands-on veterinary examination. Drug doses depend on your dog’s complete clinical picture, concurrent medications, and the exact product formulation. Always confirm dosing with your veterinarian before administering any medication, and contact a 24-hour veterinary emergency service or animal poison control immediately if you suspect a medication overdose or adverse reaction. PuppaDogs editorial standards: every drug dose published here is cross-checked against multiple authoritative veterinary references and reviewed by the PuppaDogs Veterinary Editorial Team before publication.
